Virtual West Oncology Conference


 

2021 Advanced NSCLC Targeted Therapy Updates: Efficacy & Safety Profile of Larotrectinib & Entrectinib for NTRK Fusion, Dabrafenib+Trametinib Combo in BRAF Mutated Disease

151 views
March 4, 2021
Comments 0
Login to view comments. Click here to Login